Kintz Samuel

CIK 00019671681 companyBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001967168

Recent Transactions

50 trades

Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-11-17$21.82/sh−12,500→ 890,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-10-17$21.33/sh−12,500→ 902,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-26$20.06/sh−3,700→ 915,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-23$20.03/sh−2,800→ 919,092 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-19$20.25/sh−1,000→ 921,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-09-17$19.09/sh−5,000→ 922,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-20$20.00/sh−1,517→ 927,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-19$20.00/sh−590→ 929,409 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-08-18$20.02/sh−10,393→ 929,999 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-17$22.69/sh−4,687→ 944,055 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-17$23.37/sh−3,663→ 940,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-07-17$21.58/sh−4,150→ 948,742 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-17$22.08/sh−10,502→ 954,890 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-17$22.75/sh−1,998→ 952,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-06-03$20.05/sh−7,500→ 965,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-19$16.49/sh−5,000→ 972,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-02$20.00/sh−2,170→ 977,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-05-01$20.08/sh−5,330→ 980,062 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-04-17$16.42/sh−5,000→ 985,392 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2025-03-17$20.83/sh−12,500→ 990,392 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+490,000→ 490,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−924→ 1,002,892 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-09$28.53/sh−2,830→ 1,003,816 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-09$28.07/sh−13,880→ 1,006,646 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$27.95/sh−13,167→ 1,020,626 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$28.51/sh−100→ 1,020,526 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-07$27.50/sh−2,730→ 1,033,793 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-04$27.51/sh−12,206→ 1,036,523 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-01$27.54/sh−526→ 1,048,729 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-08-26$22.89/sh−12,000→ 1,049,255 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-31$27.56/sh−2,270→ 1,061,255 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-25$25.83/sh−43→ 1,063,525 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-25$24.53/sh−3,793→ 1,071,732 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-07-25$25.10/sh−8,164→ 1,063,568 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-06-25$21.63/sh−11,422→ 1,076,103 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-06-25$22.30/sh−578→ 1,075,525 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-05-28−12,000→ 188,841 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-28$24.34/sh−100→ 0 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-28$23.57/sh−5,219→ 100 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-28$22.86/sh−6,681→ 5,319 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-28$1.12/sh+12,000→ 12,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-25$16.89/sh−12,000→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-25−12,000→ 200,841 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-25$1.12/sh+12,000→ 12,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.04/sh−47,709→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−47,709→ 212,841 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$1.12/sh+47,709→ 47,709 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-03-25$1.12/sh+12,000→ 12,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-03-25$17.17/sh−7,329→ 4,671 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-03-25−12,000→ 260,550 total

Companies

Enliven Therapeutics, Inc.
Director, PRESIDENT AND CEO
$ELVN

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301

View on SEC.gov